Tento T, Kume A, Kumaso S. Risk factors for stroke-related functional disability and mortality at Felege Hiwot Referral Hospital, Ethiopia. BMC Neurol. 2023;23(1):393.

Article  PubMed  PubMed Central  Google Scholar 

Peng Y, Ngo L, Hay K, et al. Long-term survival, stroke recurrence, and life expectancy after an acute stroke in Australia and New Zealand from 2008–2017: a population-wide cohort study. Stroke. 2022;53(8):2538–48.

Article  PubMed  Google Scholar 

Topcuoglu MA. Stroke epidemiology and near future projection in Turkey: analysis of Turkey data from the global burden of disease study. Turk J Neurol. 2022;28:200–11.

Article  Google Scholar 

Virani SS, Alonso A, Benjamin EJ, et al. Heart disease and stroke statistics-2020 update: a report from the American heart association. Circulation. 2020;141(9):e139–596.

Article  PubMed  Google Scholar 

Hedegaard U, Kjeldsen LJ, Pottegård A, et al. Multifaceted intervention including motivational interviewing to support medication adherence after stroke/transient ischemic attack: a randomized trial. Cerebrovasc Dis Extra. 2014;4(3):221–34.

Article  PubMed  PubMed Central  Google Scholar 

O’Donnell MJ, Chin SL, Rangarajan S, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016;388(10046):761–75.

Article  PubMed  Google Scholar 

Hu A, Niu J, Winkelmayer WC. Oral anticoagulation in patients with end-stage kidney disease on dialysis and atrial fibrillation. Semin Nephrol. 2018;38(6):618–28.

Article  PubMed  PubMed Central  Google Scholar 

GBD Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204–22.

Article  Google Scholar 

GBD Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1223–49.

Article  Google Scholar 

Basaraba JE, Picard M, George-Phillips K, et al. Pharmacists as care providers for stroke patients: a systematic review. Can J Neurol Sci. 2018;45(1):49–55.

Article  PubMed  Google Scholar 

McAlister FA, Majumdar SR, Padwal RS, et al. Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled. CMAJ. 2014;186(8):577–84.

Article  PubMed  PubMed Central  Google Scholar 

Chiu CC, Wu SS, Lee PY, et al. Control of modifiable risk factors in ischemic stroke outpatients by pharmacist intervention: an equal allocation stratified randomized study. J Clin Pharm Ther. 2008;33(5):529–35.

Article  PubMed  Google Scholar 

Andres J, Stanton-Ameisen O, Walton S, et al. Pharmacists’ impact on secondary stroke prevention. J Pharm Pract. 2019;32(5):503–8.

Article  PubMed  Google Scholar 

Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence and long-term predictive validity of blood pressure control. Med Care. 1986;24:67–74.

Article  PubMed  Google Scholar 

Yılmaz S, Buzlu S. (2011) Side effects of medications and adherence to medication in patients using antipsychotics [in Turkish]. Florence Nightingale Hemşirelik Dergisi, 20: 93–103. Available at http://dergipark.gov.tr/iuf-nhy/issue/9007/112176. Accessed 29 July 2023.

Williams LS, Weinberger M, Harris LE, et al. Development of a stroke-specific quality of life scale. Stroke. 1999;30(7):1362–9.

Article  PubMed  Google Scholar 

Hakverdioğlu Yönt G, Khorshid L. Turkish version of the stroke-specific quality of life scale. Int Nurs Rev. 2012;59(2):274–80.

Article  PubMed  Google Scholar 

Nguyen T, Nguyen TH, Nguyen PT, et al. Pharmacist-led intervention to enhance medication adherence in patients with acute coronary syndrome in Vietnam: a randomized controlled trial. Front Pharmacol. 2018;9:656.

Article  PubMed  PubMed Central  Google Scholar 

Ho PM, Lambert-Kerzner A, Carey EP, et al. Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial. JAMA Intern Med. 2014;174(2):186–93.

Article  PubMed  Google Scholar 

Stewart K, George J, Mc Namara KP, et al. A multifaceted pharmacist intervention to improve antihypertensive adherence: a cluster-randomized, controlled trial (HAPPy trial). J Clin Pharm Ther. 2014;39(5):527–34.

Article  PubMed  Google Scholar 

Wang J, Wang J, Qiu S, et al. Pharmaceutical care program for ischemic stroke patients: a randomized controlled trial. Int J Clin Pharm. 2021;43(5):1412–9.

Article  PubMed  Google Scholar 

Hohmann C, Klotz JM, Radziwill R, et al. Pharmaceutical care for patients with ischemic stroke: improving the patients quality of life. Pharm World Sci. 2009;31(5):550–8.

Article  PubMed  Google Scholar 

Firat O, Arsava EM, Togay-Isikay C, et al. Clinical pharmacist’s contribution to treatment adherence and quality of life in patients with stroke. Brain Inj. 2023;37(2):134–9.

Article  PubMed  Google Scholar 

Nathans AM, Bhole R, Finch CK, et al. Impact of a pharmacist-driven poststroke transitions of care clinic on 30 and 90-Day hospital readmission rates. J Stroke Cerebrovasc Dis. 2020;29(4):104648.

Article  PubMed  Google Scholar 

Hohmann C, Neumann-Haefelin T, Klotz JM, et al. Drug-related problems in patients with ischemic stroke in hospital. Int J Clin Pharm. 2012;34(6):828–31.

Article  PubMed  Google Scholar 

Basheti IA, Ayasrah SM, Ahmad M. Identifying treatment related problems and associated factors among hospitalized post-stroke patients through medication management review: a multi-center study. Saudi Pharm J. 2019;27(2):208–19.

Article  PubMed  Google Scholar 

Tian L, Wu J, Qi Z, et al. Drug-related problems among community-dwelling elderly with ischemic stroke in China. Adv Clin Exp Med. 2023;32(4):423–32.

Article  PubMed  Google Scholar 

Semcharoen K, Supornpun S, Nathisuwan S, et al. Characteristic of drug-related problems and pharmacists’ interventions in a stroke unit in Thailand. Int J Clin Pharm. 2019;41(4):880–7.

Article  PubMed  Google Scholar 

Chen Q, Jin Z, Zhang P, et al. Characteristics of drug-related problems among hospitalized ischemic stroke patients in China. Int J Clin Pharm. 2020;42(4):1237–41.

Article  PubMed  Google Scholar 

Yeo SH, Toh MPHS, Lee SH, et al. Impact of medication nonadherence on stroke recurrence and mortality in patients after first-ever ischemic stroke: insights from registry data in Singapore. Pharmacoepidemiol Drug Saf. 2020;29(5):538–49.

Article  PubMed  Google Scholar 

Widjaja KK, Chulavatnatol S, Suansanae T, et al. Knowledge of stroke and medication adherence among patients with recurrent stroke or transient ischemic attack in Indonesia: a multi-center, cross-sectional study. Int J Clin Pharm. 2021;43(3):666–72.

Article  PubMed  Google Scholar